However, they shared this statement to SELF: Semaglutides efficacy and safety have been extensively demonstrated in people with obesity/overweight with robust evidence for improving health outcomes
Clinical Evidence on GLP-1 and Heartburn Reports In clinical trials of semaglutide, gastrointestinal side effects including nausea, constipation, and diarrhea were documented more frequently than heartburn specifically
S., Wall-Wieler, E., Zheng, F., & Sharaiha, R
No natural supplement matches prescription GLP-1 medication efficacy
It is approved to reduce excess visceral fat in HIV-associated lipodystrophy , not for general weight loss or cosmetic fat reduction, and the effect reverses when treatment stops
This dual action of supporting inflammation regulation and potentially alleviating pain highlights its potential as a versatile therapeutic agent